OMER 241115 2.00C (OMER241115C2000) Stock Options, News & Quotes

US OptionsDetailed Quotes

OMER241115C2000

Watchlist

2.00
0.000.00%

15min DelayTrading Jun 7 10:24 ET

0.00High0.00Low

Intraday

5D
Daily

News

Omeros Receives Rare Pediatric Disease Designation for Zaltenibart From FDA
TipRanksOct 24 09:06 ET
Express News | FDA Grants Rare Pediatric Disease Designation to Omeros’ Masp-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy
ReutersOct 24 08:45 ET
Needham Sticks to Its Hold Rating for Omeros (OMER)
TipRanksAug 8 08:02 ET
Omeros: Q2 Earnings Snapshot
Yahoo FinanceAug 7 17:16 ET
Express News | Omeros Q2 2024 GAAP EPS $(0.97) Beats $(1.14) Estimate
BenzingaAug 7 16:46 ET
Omeros | 10-Q: Q2 2024 Earnings Report
SECAug 7 16:15 ET · Announcements

Comments

Jaguar8

Oct 24 07:45

NEWS

$Omeros (OMER.US)$
FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy
Omeros announced that its MASP-3 inhibitor zaltenibart (OMS906) received rare pediatric disease designation from the FDA for treating C3 glomerulopathy (C3G), an ultra-rare renal disorder affecting children and young adults. The company plans to initiate Phase 3 trials for C3G in 2024. Zaltenibart is also being developed for paroxysmal nocturnal hemoglob...

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Bigmoney Dreamer

Dec 7, 2023 00:49

$Omeros (OMER.US)$ uptrending nicely ! 💪🏼

wooper

Nov 24, 2023 11:29

Share Your Profit/Loss

Trytosaveabit

Nov 3, 2023 08:12

Update

$Omeros (OMER.US)$ Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
7 MINUTES AGO, 9:05 AM EDT